Tigecycline and inducible clindamycin resistance in clinical isolates of methicillin-resistant Staphylococcus aureus from Terengganu, Malaysia

References

1. Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009; 7:629–641 [View Article]
   [Google Scholar]
2. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003; 41:4740–4744 [View Article]
   [Google Scholar]
3. Jarajreh D, Aqel A, Alzoubi H, Al-Zereini W. Prevalence of inducible clindamycin resistance in methicillin-resistant Staphylococcus aureus: the first study in Jordan. J Infect Dev Ctries 2017; 11:350–354 [View Article]
   [Google Scholar]
4. Pfaller MA, Huband MD, Streit JM, Flamm RK, Sader HS. Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016). Int J Antimicrob Agents 2018; 51:848–853 [View Article]
   [Google Scholar]
5. Yang Q, Xu YC, Kiratisin P, Dowzicky MJ. Antimicrobial activity among Gram-positive and Gram-negative organisms collected from the Asia-Pacific region as part of the tigecycline evaluation and surveillance trial: comparison of 2015 results with previous years. Diagn Microbiol Infect Dis 2017; 89:314–323 [View Article]
   [Google Scholar]
6. Chen CJ, Huang YC. New epidemiology of Staphylococcus aureus infection in Asia. Clin Microbiol Infect 2014; 20:605–623 [View Article]
   [Google Scholar]
7. Institute for Medical Research Malaysian One Health Antimicrobial Resistance. Malaysian National Surveillance of Antimicrobial Resistance (NSAR) report 2017 Kuala Lumpur: National Institutes of Health (NIH) Malaysia; 2018 https://www.imr.gov.my/MyOHAR/index.php/site/archive_rpt
8. Drinkovic D, Fuller ER, Shore KP, Holland DJ, Ellis-Pegler R. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother 2001; 48:315–316 [View Article]
   [Google Scholar]
9. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002; 34:482–492 [View Article]
   [Google Scholar]
10. Levin TP, Suh B, Axelrod P, Truant AL, Fekete T. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob Agents Chemother 2005; 49:1222–1224 [View Article]
    [Google Scholar]
11. Mallick S, Basak S, Bose S. Inducible clindamycin resistance in Staphylococcus aureus-a therapeutic challenge. J Clin Diagn Res 2009; 3:1513–1518
    [Google Scholar]
12. Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, 26th ed. Wayne, PA: Clinical & Laboratory Standards Institute; 2016
    [Google Scholar]
13. Puah SM, Chua KH, Tan JA. Virulence factors and antibiotic susceptibility of Staphylococcus aureus isolates in ready-to-eat foods: detection of S. aureus contamination and a high prevalence of virulence genes. Int J Environ Res Public Health 2016; 13:199 [View Article]
    [Google Scholar]
14. European Committee on Antimicrobial Susceptibility Testing The European Committee on antimicrobial susceptibility testing. Breakpoint tables for interpretation of MICs and zone diameters, version 6.0: European Committee on antimicrobial susceptibility testing ; 2016
15. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268–281 [View Article]
    [Google Scholar]
16. Centers for Disease Control and Prevention Active bacterial core surveillance report, emerging infections program network, methicillin resistant Staphylococcus aureus, 2015. Centers for Disease Control and Prevention; 2015
17. David MZ, Boyle-Vavra S, Zychowski DL, Daum RS. Methicillin-susceptible Staphylococcus aureus as a predominantly healthcare-associated pathogen: a possible reversal of roles?. PLoS One 2011; 6:e18217 [View Article]
    [Google Scholar]
18. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000–2006. J Infect Dis 2008; 198:336–343 [View Article]
    [Google Scholar]
19. Pogorzelska-Maziarz M, Furuya EY, Larson EL. Risk factors for methicillin-resistant Staphylococcus aureus bacteraemia differ depending on the control group chosen. Epidemiol Infect 2013; 141:2376–2383 [View Article]
    [Google Scholar]
20. Bourgeois-Nicolaos N, Lucet JC, Daubié C, Benchaba F, Rajguru M et al. Maternal vaginal colonisation by Staphylococcus aureus and newborn acquisition at delivery. Paediatr Perinat Epidemiol 2010; 24:488–491 [View Article]
    [Google Scholar]
21. Lim KT, Hanifah YA, Mohd Yusof MY, Ito T, Thong KL. Comparison of methicillin-resistant Staphylococcus aureus strains isolated in 2003 and 2008 with an emergence of multidrug resistant ST22: SCCmec IV clone in a tertiary hospital, Malaysia. J Microbiol Immunol Infect 2013; 46:224–233 [View Article]
    [Google Scholar]
22. Micek ST. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2007; 45:S184–S190 [View Article]
    [Google Scholar]
23. Atshan SS, Nor Shamsudin M, Lung LT, Sekawi Z, Pei Pei C et al. Genotypically different clones of Staphylococcus aureus are diverse in the antimicrobial susceptibility patterns and biofilm formations. Biomed Res Int 2013; 2013:515712 [View Article]
    [Google Scholar]
24. Haim MS, Di Gregorio S, Galanternik L, Lubovich S, Vázquez M et al. First description of rpsJ and mepA mutations associated with tigecycline resistance in Staphylococcus aureus isolated from a cystic fibrosis patient during antibiotic therapy. Int J Antimicrob Agents 2017; 50:739–741 [View Article]
    [Google Scholar]
25. Ben-David D, Novikov I, Mermel LA. Are there differences in hospital cost between patients with nosocomial methicillin-resistant Staphylococcus aureus bloodstream infection and those with methicillin-susceptible S. aureus bloodstream infection?. Infect Control Hosp Epidemiol 2009; 30:453–460 [View Article]
    [Google Scholar]
26. Joo EJ, Park DA, Kang CI, Chung DR, Song JH et al. Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis. Korean J Intern Med 2018 [View Article]
    [Google Scholar]
27. Song JH, Hsueh PR, Chung DR, Ko KS, Kang C-I et al. Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study. J Antimicrob Chemother 2011; 66:1061–1069 [View Article]
    [Google Scholar]
28. Sit PS, Teh CS, Idris N, Sam IC, Syed Omar SF et al. Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) infection and the molecular characteristics of MRSA bacteraemia over a two-year period in a tertiary teaching hospital in Malaysia. BMC Infect Dis 2017; 17:274 [View Article]
    [Google Scholar]
29. Huang H, Flynn NM, King JH, Monchaud C, Morita M et al. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. J Clin Microbiol 2006; 44:2423–2427 [View Article]
    [Google Scholar]
30. Rashid ZZ, Bahari N, Othman A, Jaafar R, Mohamed NA et al. Community-acquired methicillin-resistant Staphylococcus aureus in a Malaysian tertiary centre. Southeast Asian J Trop Med Public Health 2013; 44:104–108
    [Google Scholar]
31. David MZ, Cadilla A, Boyle-Vavra S, Daum RS. Replacement of HA-MRSA by CA-MRSA infections at an academic medical center in the midwestern United States, 2004-5 to 2008. PLoS One 2014; 9:e92760 [View Article]
    [Google Scholar]
32. Uhlemann AC, Otto M, Lowy FD, DeLeo FR. Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus . Infect Genet Evol 2014; 21:563–574 [View Article]
    [Google Scholar]
33. Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40:4289–4294 [View Article]
    [Google Scholar]
34. Yang Y, Hu Z, Shang W, Hu Q, Zhu J et al. Molecular and phenotypic characterization revealed high prevalence of multidrug-resistant methicillin-susceptible Staphylococcus aureus in Chongqing, Southwestern China. Microb Drug Resist 2017; 23:241–246 [View Article]
    [Google Scholar]
35. Ayau P, Bardossy AC, Sanchez G, Ortiz R, Moreno D et al. Risk factors for 30-day mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infections. Int J Infect Dis 2017; 61:3–6 [View Article]
    [Google Scholar]